Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02808078
Other study ID # CliniqueRR-04
Secondary ID
Status Recruiting
Phase N/A
First received June 14, 2016
Last updated December 5, 2017
Start date June 2016
Est. completion date December 2018

Study information

Verified date December 2017
Source Clinique Romande de Readaptation
Contact Philippe Terrier, PhD
Phone +41 27 603 2077
Email Philippe.Terrier@crr-suva.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The GASPAR trial is a pragmatic, parallel-arms, single-center, non-blinded, superiority randomized control trial in neurorehabilitation. The main objective is to test whether a 4 weeks gait rehabilitation program that uses augmented reality is superior to a conventional treadmill training program of equivalent intensity. Baseline assessments precede allocation, which consists in blocking randomization (2:1 ratio) with stratification according to the disease etiology. Post-intervention assessments serve to compare the short-term efficacy of the intervention between the two groups. Three months after discharge, follow-up assessments take place to detect potential long-term effects.


Description:

After a lesion to the central nervous system, many patients suffer from a diminished walking capability. During the first rehabilitation phase, specific cares help the recovery of motor function to offer the best chances of returning to normal walk. For example, the repeated practice of walking exercises facilitates the gain of muscular strength and stimulates motor relearning. However, in patients, who have finished the first rehabilitation phase, it is often observed strong limping, unsteady gait, and a bad management of obstacle clearance. Thus, these individuals fall frequently, with risk of severe injury. The aim of the study is to assess the efficacy of gait training on a treadmill equipped with an augmented reality system. Shapes are displayed onto the treadmill belt with a projector (beamer): the patient adapts his/her gait to the drawing that unfolds in front of him/her. It is possible to train gait symmetry for coordination enhancement or to exercise obstacle clearance and gait agility. Another advantage of this type of treadmill is the capability to continuously analyze gait with integrated sensors and, hence, to give real-time feedback to the patient. Whereas the method seems promising, thorough studies that would confirm its efficacy are lacking. Therefore, the investigators seek to conduct a randomized controlled trial to compare visually-guided gait training with a more classical training method. During four weeks, participants will train, according to their abilities, three to five times a week during 30 minutes on the augmented-reality treadmill. A group of control patients will train at comparable intensity but without the visual guidance of gait. Using the data collected during the training sessions, the investigators will study whether the evolution of locomotor function differs between both groups. Furthermore, several questionnaires will be filled in by the participants to document the self-evaluation of their progress. In the long term, the investigators expect to first improve the efficacy of gait rehabilitation and second to better understand the recovery process of locomotor function during the first months after a stroke.


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date December 2018
Est. primary completion date July 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Participants fulfilling all of the following inclusion criteria are eligible for the study:

- Informed Consent as documented by signature

- Stroke patients, patients with traumatic brain injury, or patients with spinal cord injury in the acute to sub-acute phase (maximum 40 days after the incident)

- Need for gait rehabilitation in reason of at least one of the following conditions: Paresis of the lower extremities. Severe balance disorders. No walking at entry due to the neurological injury

- Ability to walk 2 minutes without or with minimal aid, namely: With the help of one person, or: With walking aid (cane, walker)

The presence of any one of the following exclusion criteria will lead to exclusion of the participant:

- Age < 18 years

- Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.) that may threaten the health in case of sustained exercise.

- Concomitant gait disorders induced by acute to sub-acute musculoskeletal injuries, e.g. fracture of the lower extremities.

- Severe pre-existent gait disorders that deeply affect walking abilities and gait pattern, either due to musculoskeletal (e.g. severe osteoarthritis) or neurological (e.g. Parkinson's disease) etiologies.

- Severe non-corrected visual impairment

- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.

Study Design


Intervention

Device:
Gait training with augmented reality
20 sessions (30 min. duration) over 4 weeks of gait training with augmented reality.
Standard training
20 sessions (30 min. duration) over 4 weeks of gait training without augmented reality.

Locations

Country Name City State
Switzerland Clinique Romande de Réadaptation Sion Valais

Sponsors (2)

Lead Sponsor Collaborator
Philippe Terrier Swiss Heart Foundation

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in walking speed Walking speed, measured with the 2-minute walk test Pre-intervention (week 0), Post-intervention (week 5)
Secondary Change in postural control Capabilities to ensure an optimal postural control. Measured with the Berg Balance test Pre-intervention (week 0), Post-intervention (week 5)
Secondary Fear of falling during the hospitalization Subjective assessment of the fear of falling. Measured with the adapted Falls Efficacy Scale (FES) week 5
Secondary Fear of falling at home Subjective assessment of the fear of falling. Measured with the adapted Falls Efficacy Scale (FES) after discharge at 3-4 month
Secondary Quality of life at home Short-Form 36 questionnaire (SF-36) after discharge at 3-4 month
Secondary Perception of the intervention purpose-designed questionnaire that will ask to the participant about their perception of the intervention. The questionnaire will evaluate the satisfaction with intensity, duration and difficulty of the intervention. Other questions will ask about the perceived training effects on walking speed and confidence. During the intervention, week 2 and 4
Secondary Changes in stride and step lengths Measured with the embedded sensors of the treadmills In every gait training sessions, from week 1 to week 4
Secondary Changes in stride and step durations Measured with the embedded sensors of the treadmills In every gait training sessions, from week 1 to week 4
Secondary Change in step width Measured with the embedded sensors of the treadmills In every gait training sessions, from week 1 to week 4
Secondary Change in left/right asymmetry of step lengths Measured with the embedded sensors of the treadmills In every gait training sessions, from week 1 to week 4
Secondary Change in left/right asymmetry of step durations Measured with the embedded sensors of the treadmills In every gait training sessions, from week 1 to week 4
Secondary Changes in stance and swing phases Measured with the embedded sensors of the treadmills In every gait training sessions, from week 1 to week 4
Secondary Change in gait variability Stride-to-stride variability of gait parameters (outcomes 7-12) In every gait training sessions, from week 1 to week 4
See also
  Status Clinical Trial Phase
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Recruiting NCT03869138 - Alternative Therapies for Improving Physical Function in Individuals With Stroke N/A
Completed NCT04034069 - Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial N/A
Completed NCT04101695 - Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Completed NCT00391378 - Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS) N/A
Recruiting NCT06204744 - Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial N/A
Active, not recruiting NCT06043167 - Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
Active, not recruiting NCT04535479 - Dry Needling for Spasticity in Stroke N/A
Completed NCT03985761 - Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke N/A
Recruiting NCT00859885 - International PFO Consortium N/A
Recruiting NCT06034119 - Effects of Voluntary Adjustments During Walking in Participants Post-stroke N/A
Completed NCT03622411 - Tablet-based Aphasia Therapy in the Chronic Phase N/A
Completed NCT01662960 - Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke N/A
Recruiting NCT05854485 - Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke N/A
Active, not recruiting NCT05520528 - Impact of Group Participation on Adults With Aphasia N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT05805748 - Serious Game Therapy in Neglect Patients N/A
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT05993221 - Deconstructing Post Stroke Hemiparesis